These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8231842)

  • 1. Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS).
    Watts GF; Mandalia S; Brunt JN; Slavin BM; Coltart DJ; Lewis B
    Metabolism; 1993 Nov; 42(11):1461-7. PubMed ID: 8231842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS).
    Watts GF; Lewis B; Brunt JN; Lewis ES; Coltart DJ; Smith LD; Mann JI; Swan AV
    Lancet; 1992 Mar; 339(8793):563-9. PubMed ID: 1347091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
    Watts GF; Pang J; Chan DC; Brunt JNH; Lewis B
    Atherosclerosis; 2016 Sep; 252():82-87. PubMed ID: 27508319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic determinants of the course of coronary artery disease in men.
    Watts GF; Mandalia S; Slavin BM; Brunt JN; Coltart DJ; Lewis B
    Clin Chem; 1994 Dec; 40(12):2240-6. PubMed ID: 7988012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
    Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.
    Krauss RM; Lindgren FT; Williams PT; Kelsey SF; Brensike J; Vranizan K; Detre KM; Levy RI
    Lancet; 1987 Jul; 2(8550):62-6. PubMed ID: 2885572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease.
    Williams PT; Zhao XQ; Marcovina SM; Otvos JD; Brown BG; Krauss RM
    Atherosclerosis; 2014 Apr; 233(2):713-720. PubMed ID: 24603218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol Subfraction Analysis in Patients with Acute Coronary Syndrome.
    Kidawa M; Gluba-Brzózka A; Zielinska M; Franczyk B; Banach M; Rysz J
    Curr Vasc Pharmacol; 2019; 17(4):365-375. PubMed ID: 29852873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
    Ruotolo G; Ericsson CG; Tettamanti C; Karpe F; Grip L; Svane B; Nilsson J; de Faire U; Hamsten A
    J Am Coll Cardiol; 1998 Nov; 32(6):1648-56. PubMed ID: 9822092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
    Kuster GM; Amann FW; Neuenschwander C; Drexel H
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):127-31. PubMed ID: 12090905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group.
    Sacks FM; Pasternak RC; Gibson CM; Rosner B; Stone PH
    Lancet; 1994 Oct; 344(8931):1182-6. PubMed ID: 7934538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression.
    Mack WJ; Krauss RM; Hodis HN
    Arterioscler Thromb Vasc Biol; 1996 May; 16(5):697-704. PubMed ID: 8963728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrient intake and progression of coronary artery disease.
    Watts GF; Jackson P; Mandalia S; Brunt JN; Lewis ES; Coltart DJ; Lewis B
    Am J Cardiol; 1994 Feb; 73(5):328-32. PubMed ID: 8109545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.
    de Graaf J; Swinkels DW; Demacker PN; de Haan AF; Stalenhoef AF
    J Clin Endocrinol Metab; 1993 Jan; 76(1):197-202. PubMed ID: 8421088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sialic acid as an indicator of change in coronary artery disease.
    Watts GF; Crook MA; Haq S; Mandalia S
    Metabolism; 1995 Feb; 44(2):147-8. PubMed ID: 7869908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L; Kramsch DM; Azen SP; DeMets D; DeBoer LW; Hwang I; Vailas L; Hirsch LJ; Mack WJ; DeBoer L
    Online J Curr Clin Trials; 1992 Oct; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.